Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 08:33 am Sale | 2023-12-31 | 13G | Albireo Pharma, Inc. ALBO | Deep Track Capital LP | 0 0.000% | -1,704,000 (Position Closed) | Filing History |
| 2023-04-10 11:22 am Sale | 2023-03-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 0 0.000% | -1,956,488 (Position Closed) | Filing History |
| 2023-03-08 2:01 pm Sale | 2023-02-28 | 13G | Albireo Pharma, Inc. ALBO | BlackRock Inc. BLK | 506,425 2.400% | -838,472 (-62.34%) | Filing History |
| 2023-03-02 4:26 pm Purchase | 2023-02-21 | 13G | Albireo Pharma, Inc. ALBO | ICS OPPORTUNITIES LTD. | 999,363 4.800% | 999,363 (New Position) | Filing History |
| 2023-02-27 4:05 pm Purchase | 2023-02-16 | 13G | Albireo Pharma, Inc. ALBO | Beryl Capital Management LLC | 1,483,599 7.100% | 1,483,599 (New Position) | Filing History |
| 2023-02-24 5:24 pm Purchase | 2023-02-17 | 13G | Albireo Pharma, Inc. ALBO | CARLSON CAPITAL L P | 1,075,000 5.200% | 1,075,000 (New Position) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | TANG CAPITAL PARTNERS LP | 411,968 2.000% | -687,548 (-62.53%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | PERCEPTIVE ADVISORS LLC | 1,757,160 8.500% | -602,979 (-25.55%) | Filing History |
| 2023-02-14 08:23 am Purchase | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | Deep Track Capital LP | 1,704,000 8.230% | 579,579 (+51.54%) | Filing History |
| 2023-02-01 09:56 am Sale | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | STATE STREET CORP STT | 348,114 1.680% | -644,718 (-64.94%) | Filing History |
| 2023-02-01 09:07 am Sale | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 1,956,488 9.450% | -402,136 (-17.05%) | Filing History |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | BlackRock Inc. BLK | 1,344,897 6.500% | 176,114 (+15.07%) | Filing History |
| 2023-01-23 12:49 pm Purchase | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | Chicago Capital LLC | 1,362,484 6.600% | 390,599 (+40.19%) | Filing History |
| 2022-10-03 4:37 pm Purchase | 2022-09-23 | 13G | Albireo Pharma, Inc. ALBO | Deep Track Capital LP | 1,124,421 5.460% | 1,124,421 (New Position) | Filing History |
| 2022-09-26 4:00 pm Purchase | 2022-09-15 | 13G | Albireo Pharma, Inc. ALBO | TANG CAPITAL PARTNERS LP | 1,099,516 5.600% | 1,099,516 (New Position) | Filing History |
| 2022-03-07 08:56 am Purchase | 2022-03-01 | 13G | Albireo Pharma, Inc. ALBO | Chicago Capital LLC | 971,885 5.100% | 971,885 (New Position) | Filing History |
| 2022-02-14 4:10 pm Unchanged | 2021-12-31 | 13G | Albireo Pharma, Inc. ALBO | PERCEPTIVE ADVISORS LLC | 2,360,139 12.200% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:38 pm Sale | 2021-12-31 | 13G | Albireo Pharma, Inc. ALBO | FEDERATED HERMES INC. FHI | 2,358,624 12.230% | -88,376 (-3.61%) | Filing History |
| 2022-02-09 4:49 pm Purchase | 2021-12-31 | 13G | Albireo Pharma, Inc. ALBO | STATE STREET CORP STT | 992,832 5.150% | 992,832 (New Position) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Albireo Pharma, Inc. ALBO | BlackRock Inc. BLK | 1,168,783 6.100% | -73,997 (-5.95%) | Filing History |